The VEGF-induced PFKP expression was blocked by pretreatment of SU1498, a VEGFR2 tyrosine kinase inhibitor, in GBM cells (Fig. 5I and Supplementary Fig. S5J), indicating VEGFR-dependent VEGF signaling. This evidence concerns the gene KDR and glioblastoma.